Health-economic modelling to inform private sector investment in infectious disease treatments in middle-income countries: The case of tuberculosis

Abstract

Progress in developing of better infectious disease treatments in middle-income countries is slow, creating a need to incentivize increased private sector investment. The Bill & Melinda Gates Foundation (BMGF) commissioned the development of a health-economic model for measuring, aggregating, monetizing, and securitizing future middle-income country demand for better tuberculosis (TB) treatments, and stimulate research and development (R&D).